Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← Analysis & Perspectives
AvalereAugust 7, 2026

Medicare Drug Price Negotiation Refund Rules Could Create Varying Burdens for Medicaid MCOs Based on Drug Discount Profiles

CMS's proposed standardized refund methodologies under the Medicare Drug Negotiation Program would calculate manufacturer rebates differently depending on whether drugs have deep existing discounts or not, creating varying financial impacts across competitive drug classes. This matters for Medicaid managed care because the Medicare negotiated prices will serve as benchmarks and could reshape manufacturer pricing strategies and discount structures that MCOs rely on for pharmacy benefits. Plans with formularies weighted toward either high-discount or low-discount competitive classes may face different financial exposure as these Medicare pricing policies take effect.

Pharmacy · Managed Care

Read the full analysis at Avalere →

This is outside commentary from Avalere, not part of Medicaid Monitor's independently scored news coverage.

Share this

More from Avalere

← Analysis & Perspectives

Get the daily briefing.